Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2021

Open Access 01-12-2021 | Amyotrophic Lateral Sclerosis | Research article

Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews

Authors: Alexios-Fotios A. Mentis, Efthimios Dardiotis, Vasiliki Efthymiou, George P. Chrousos

Published in: BMC Medicine | Issue 1/2021

Login to get access

Abstract

Background

The etiologies of chronic neurological diseases, which heavily contribute to global disease burden, remain far from elucidated. Despite available umbrella reviews on single contributing factors or diseases, no study has systematically captured non-purely genetic risk and/or protective factors for chronic neurological diseases.

Methods

We performed a systematic analysis of umbrella reviews (meta-umbrella) published until September 20th, 2018, using broad search terms in MEDLINE, SCOPUS, Web of Science, Cochrane Database of Systematic Reviews, Cumulative Index to Nursing and Allied Health Literature, ProQuest Dissertations & Theses, JBI Database of Systematic Reviews and Implementation Reports, DARE, and PROSPERO. The PRISMA guidelines were followed for this study. Reference lists of the identified umbrella reviews were also screened, and the methodological details were assessed using the AMSTAR tool. For each non-purely genetic factor association, random effects summary effect size, 95% confidence and prediction intervals, and significance and heterogeneity levels facilitated the assessment of the credibility of the epidemiological evidence identified.

Results

We identified 2797 potentially relevant reviews, and 14 umbrella reviews (203 unique meta-analyses) were eligible. The median number of primary studies per meta-analysis was 7 (interquartile range (IQR) 7) and that of participants was 8873 (IQR 36,394). The search yielded 115 distinctly named non-genetic risk and protective factors with a significant association, with various strengths of evidence. Mediterranean diet was associated with lower risk of dementia, Alzheimer disease (AD), cognitive impairment, stroke, and neurodegenerative diseases in general. In Parkinson disease (PD) and AD/dementia, coffee consumption, and physical activity were protective factors. Low serum uric acid levels were associated with increased risk of PD. Smoking was associated with elevated risk of multiple sclerosis and dementia but lower risk of PD, while hypertension was associated with lower risk of PD but higher risk of dementia. Chronic occupational exposure to lead was associated with higher risk of amyotrophic lateral sclerosis. Late-life depression was associated with higher risk of AD and any form of dementia.

Conclusions

We identified several non-genetic risk and protective factors for various neurological diseases relevant to preventive clinical neurology, health policy, and lifestyle counseling. Our findings could offer new perspectives in secondary research (meta-research).
Appendix
Available only for authorised users
Literature
1.
Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97.
2.
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132–40.PubMed
3.
Organization WH. World report on ageing and health. Geneva: World Health Organization; 2015.
4.
Finlay BB, Humans C. Microbiome. Are noncommunicable diseases communicable? Science (New York). 2020;367(6475):250–1.
5.
Karikari TK, Charway-Felli A, Höglund K, Blennow K, Zetterberg H. Commentary: global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Front Neurol. 2018;9:201.PubMedPubMedCentral
6.
Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and endogenous retroviruses in multiple sclerosis: from correlation to causation. Acta Neurol Scand. 2017;136(6):606–16.PubMed
7.
Little J, Barakat-Haddad C, Martino R, Pringsheim T, Tremlett H, McKay KA, et al. Genetic variation associated with the occurrence and progression of neurological disorders. Neurotoxicology. 2017;61:243–64.PubMed
8.
9.
10.
Allen LN, Nicholson BD, Yeung BY, Goiana-da-Silva F. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries. Lancet Glob Health. 2019;8:e50–e58.
11.
12.
Qi X, Wang S, Zhang L, Liu L, Wen Y, Ma M, et al. An integrative analysis of transcriptome-wide association study and mRNA expression profile identified candidate genes for attention-deficit/hyperactivity disorder. Psychiatry Res. 2019;282:112639.PubMed
13.
Liao C, Laporte AD, Spiegelman D, Akçimen F, Joober R, Dion PA, et al. Transcriptome-wide association study of attention deficit hyperactivity disorder identifies associated genes and phenotypes. Nat Commun. 2019;10(1):4450.PubMedPubMedCentral
14.
Gusev A, Mancuso N, Won H, Kousi M, Finucane HK, Reshef Y, et al. Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet. 2018;50(4):538–48.PubMedPubMedCentral
15.
Khoury MJ, Bertram L, Boffetta P, Butterworth AS, Chanock SJ, Dolan SM, et al. Genome-wide association studies, field synopses, and the development of the knowledge base on genetic variation and human diseases. Am J Epidemiol. 2009;170(3):269–79.PubMedPubMedCentral
16.
Hadjigeorgiou GM, Kountra PM, Koutsis G, Tsimourtou V, Siokas V, Dardioti M, et al. Replication study of GWAS risk loci in Greek multiple sclerosis patients. Neurol Sci. 2019;40(2):253–60.PubMed
17.
Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nature Genet. 2014;46(9):989–93.PubMed
18.
Belbasis L, Panagiotou OA, Dosis V, Evangelou E. A systematic appraisal of field synopses in genetic epidemiology: a HuGE review. Am J Epidemiol. 2015;181(1):1–16.PubMed
19.
Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, et al. The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med. 2009;11(8):559–67.PubMedPubMedCentral
20.
Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet. 2008;40(7):827–34.PubMed
21.
Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide B-MM, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: the PDGene database. PLoS Genet. 2012;8(3):e1002548.PubMedPubMedCentral
22.
Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet. 2007;39(1):17–23.PubMed
23.
Lill CM, Abel O, Bertram L, Al-Chalabi A. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotroph Lateral Scler. 2011;12(4):238–49.PubMed
24.
Zhang X, Gill D, He Y, Yang T, Li X, Monori G, et al. Non-genetic biomarkers and colorectal cancer risk: umbrella review and evidence triangulation. Cancer Med. 2020;9:4823–35.
25.
Richardson TG, Harrison S, Hemani G, Davey SG. An atlas of polygenic risk score associations to highlight putative causal relationships across the human phenome. eLife. 2019;8:e43657.
26.
Patel CJ, Bhattacharya J, Butte AJ. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS One. 2010;5(5):e10746.PubMedPubMedCentral
27.
Patel CJ, Cullen MR, Ioannidis JP, Butte AJ. Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol. 2012;41(3):828–43.PubMedPubMedCentral
28.
Patel CJ, Rehkopf DH, Leppert JT, Bortz WM, Cullen MR, Chertow GM, et al. Systematic evaluation of environmental and behavioural factors associated with all-cause mortality in the United States national health and nutrition examination survey. Int J Epidemiol. 2013;42(6):1795–810.PubMedPubMedCentral
29.
30.
Patel CJ, Ioannidis JP. Placing epidemiological results in the context of multiplicity and typical correlations of exposures. J Epidemiol Commun Health. 2014;68(11):1096–100.
31.
Patel CJ, Manrai AK. Development of exposome correlation globes to map out environment-wide associations. Pac Symp Biocomput Pac. 2015;20:231–42.
32.
33.
Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL, et al. Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol. 2019;15(10):565–81.PubMed
34.
Radua J, Ramella-Cravaro V, Ioannidis JP, Reichenberg A, Phiphopthatsanee N, Amir T, et al. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018;17(1):49–66.PubMedPubMedCentral
35.
Pruss-Ustun A, Wolf J, Corvalan C, Neville T, Bos R, Neira M. Diseases due to unhealthy environments: an updated estimate of the global burden of disease attributable to environmental determinants of health. J Public Health (Oxford). 2017;39(3):464–75.
36.
Organization WH. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
37.
Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health. 2018;21(3):95–100.PubMed
38.
Lakhani CM, Tierney BT, Manrai AK, Yang J, Visscher PM, Patel CJ. Repurposing large health insurance claims data to estimate genetic and environmental contributions in 560 phenotypes. Nat Genet. 2019;51(2):327.PubMedPubMedCentral
39.
Becker L, Oxman A. Chapter 22: Overviews of reviews In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 510 (updated March 2011) The Cochrane Collaboration, 2011. Available: www.​cochrane-handbookorg. 2011. Accessed 26 May 2020.
40.
Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181(8):488–93.PubMedPubMedCentral
41.
Ioannidis J. Next-generation systematic reviews: prospective meta-analysis, individual-level data, networks and umbrella reviews. Br J Sports Med. 2017;51(20):1456–8.PubMed
42.
Bellon JA, Moreno-Peral P, Motrico E, Rodriguez-Morejon A, Fernandez A, Serrano-Blanco A, et al. Effectiveness of psychological and/or educational interventions to prevent the onset of episodes of depression: a systematic review of systematic reviews and meta-analyses. Prev Med. 2015;76(Suppl):S22–32.PubMed
43.
Kohler CA, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L, et al. Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and Mendelian randomization studies. J Psychiatr Res. 2018;103:189–207.PubMed
44.
Apostolo J, Cooke R, Bobrowicz-Campos E, Santana S, Marcucci M, Cano A, et al. Predicting risk and outcomes for frail older adults: an umbrella review of frailty screening tools. JBI Database System Rev Implement Rep. 2017;15(4):1154–208.PubMedPubMedCentral
45.
Biondi-Zoccai G, Versaci F, Iskandrian AE, Schillaci O, Nudi A, Frati G, et al. Umbrella review and multivariate meta-analysis of diagnostic test accuracy studies on hybrid non-invasive imaging for coronary artery disease. J Nuclear Cardiol. 2018;27:1744–55.
46.
Papola D, Ostuzzi G, Gastaldon C, Morgano GP, Dragioti E, Carvalho AF, et al. Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies. Acta Psychiatr Scand. 2019;140:227–43.
47.
Ziff OJ, Samra M, Howard JP, Bromage DI, Ruschitzka F, Francis DP, et al. Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment. BMC Med. 2020;18(1):103.PubMedPubMedCentral
48.
Yang T, Li X, Montazeri Z, Little J, Farrington SM, Ioannidis JPA, et al. Gene-environment interactions and colorectal cancer risk: an umbrella review of systematic reviews and meta-analyses of observational studies. Int J Cancer. 2019;145(9):2315–29.PubMedPubMedCentral
49.
Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2017;13(4):406–18.PubMed
50.
Bellou V, Belbasis L, Tzoulaki I, Evangelou E, Ioannidis JP. Environmental risk factors and Parkinson's disease: an umbrella review of meta-analyses. Parkinsonism Relat Disord. 2016;23:1–9.PubMed
51.
Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14(3):263–73.PubMed
52.
Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.PubMedPubMedCentral
53.
Harper S. A future for observational epidemiology: clarity, credibility, transparency. Am J Epidemiol. 2019;188(5):840–5.PubMed
54.
Papatheodorou S. Umbrella reviews: what they are and why we need them. Eur J Epidemiol. 2019;34(6):543–6.PubMed
55.
Yu J-T, Xu W, Tan C-C, Andrieu S, Suckling J, Evangelou E, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91:1201–9.
56.
Mentis AF, Kararizou E. Does ageing originate in utero? Biogerontology. 2010;11(6):725–9.PubMed
57.
Heindel JJ, Balbus J, Birnbaum L, Brune-Drisse MN, Grandjean P, Gray K, et al. Developmental origins of health and disease: integrating environmental influences. Endocrinology. 2015;156(10):3416–21.PubMedPubMedCentral
58.
Anstey K, Cherbuin N, Budge M, Young J. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev. 2011;12(5):e426–e37.PubMed
59.
Tsilidis KK, Panagiotou OA, Sena ES, Aretouli E, Evangelou E, Howells DW, et al. Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol. 2013;11(7):e1001609.PubMedPubMedCentral
60.
Tzoulaki I, Siontis KC, Evangelou E, Ioannidis JP. Bias in associations of emerging biomarkers with cardiovascular disease. JAMA Intern Med. 2013;173(8):664–71.PubMed
61.
Organization WH. Neurological disorders: public health challenges. Geneva: World Health Organization; 2006.
62.
Sergentanis TN, Ntanasis-Stathopoulos I, Tzanninis IG, Gavriatopoulou M, Sergentanis IN, Dimopoulos MA, et al. Meat, fish, dairy products and risk of hematological malignancies in adults - a systematic review and meta-analysis of prospective studies. Leukemia lymphoma. 2019;60:1–13.
63.
Hersi M, Quach P, Wang MD, Gomes J, Gaskin J, Krewski D. Systematic reviews of factors associated with the onset and progression of neurological conditions in humans: a methodological overview. Neurotoxicology. 2017;61:12–8.PubMed
64.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.PubMed
65.
Shea BJ, Hamel C, Wells GA, Bouter LM, Kristjansson E, Grimshaw J, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol. 2009;62(10):1013–20.PubMed
66.
Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008.PubMedPubMedCentral
67.
Pieper D, Puljak L, González-Lorenzo M, Minozzi S. Minor differences were found between AMSTAR 2 and ROBIS in the assessment of systematic reviews including both randomized and nonrandomized studies. J Clin Epidemiol. 2019;108:26–33.PubMed
68.
Gates A, Gates M, Duarte G, Cary M, Becker M, Prediger B, et al. Evaluation of the reliability, usability, and applicability of AMSTAR, AMSTAR 2, and ROBIS: protocol for a descriptive analytic study. Syst Rev. 2018;7(1):85.PubMedPubMedCentral
69.
Solmi M, Correll CU, Carvalho AF, Ioannidis JPA. The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis. Epidemiol Psychiatric Sci. 2018;27(6):537–42.
70.
Pollock M, Fernandes RM, Hartling L. Evaluation of AMSTAR to assess the methodological quality of systematic reviews in overviews of reviews of healthcare interventions. BMC Med Res Methodol. 2017;17(1):48.PubMedPubMedCentral
71.
Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820–6.PubMed
72.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials. 1986;7(3):177–88.PubMed
73.
Posadzki PP, Bajpai R, Kyaw BM, Roberts NJ, Brzezinski A, Christopoulos GI, et al. Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action. BMC Med. 2018;16(1):18.PubMedPubMedCentral
74.
Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101–29.
75.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedPubMedCentral
76.
Grosso G, Godos J, Galvano F, Giovannucci EL. Coffee, caffeine, and health outcomes: an umbrella review. Annu Rev Nutr. 2017;37:131–56.PubMed
77.
Veronese N, Solmi M, Caruso MG, Giannelli G, Osella AR, Evangelou E, et al. Dietary fiber and health outcomes: an umbrella review of systematic reviews and meta-analyses. Am J Clin Nutr. 2018;107(3):436–44.PubMed
78.
Belbasis L, Bellou V, Evangelou E. Environmental risk factors and amyotrophic lateral sclerosis: an umbrella review and critical assessment of current evidence from systematic reviews and meta-analyses of observational studies. Neuroepidemiology. 2016;46(2):96–105.PubMed
79.
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J. Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ. 2017;359:j5024.PubMedPubMedCentral
80.
Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4(3):245–53.PubMed
81.
Dinu M, Pagliai G, Casini A, Sofi F. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2018;72(1):30.PubMed
82.
Beecroft SJ, McLean CA, Delatycki MB, Koshy K, Yiu E, Haliloglu G, et al. Expanding the phenotypic spectrum associated with mutations of DYNC1H1. Neuromuscul Disord. 2017;27(7):607–15.PubMed
83.
Veronese N, Demurtas J, Celotto S, Caruso MG, Maggi S, Bolzetta F, et al. Is chocolate consumption associated with health outcomes? An umbrella review of systematic reviews and meta-analyses. Clin Nutr. 2019;38(3):1101–8.PubMed
84.
Galbete C, Schwingshackl L, Schwedhelm C, Boeing H, Schulze MB. Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses. Eur J Epidemiol. 2018;33(10):909–31.PubMedPubMedCentral
85.
McRae MP. Health benefits of dietary whole grains: an umbrella review of meta-analyses. J Chiropr Med. 2017;16(1):10–8.PubMed
86.
Li X, Meng X, Timofeeva M, Tzoulaki I, Tsilidis KK, Ioannidis JP, Campbell H, Theodoratou E. Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies. BMJ. 2017;357:j2376. https://​doi.​org/​10.​1136/​bmj.​j2376.
87.
Serghiou S, Patel CJ, Tan YY, Koay P, Ioannidis JP. Field-wide meta-analyses of observational associations can map selective availability of risk factors and the impact of model specifications. J Clin Epidemiol. 2016;71:58–67.PubMed
88.
Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet (London). 2019;393(10170):434–45.
89.
Krewski D, Barakat-Haddad C, Donnan J, Martino R, Pringsheim T, Tremlett H, et al. Determinants of neurological disease: synthesis of systematic reviews. Neurotoxicology. 2017;61:266–89.PubMed
90.
Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cruz-Jentoft A, Petrovic M, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ Open. 2017;7(3):e012759.PubMedPubMedCentral
91.
Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2018;30(3):295–309.PubMed
92.
Gillett G, Tomlinson A, Efthimiou O, Cipriani A. Predicting treatment effects in unipolar depression: a meta-review. Pharmacol Ther. 2020;212:107557.PubMed
93.
Patel B, Legacy J, Hegland KW, Okun MS, Herndon NE. A comprehensive review of the diagnosis and treatment of Parkinson's disease dysphagia and aspiration. Expert Rev Gastroenterol Hepatol. 2020;14(6):411–24.PubMed
94.
Puljak L, Pieper D. Registration of methodological studies, that is, “research-on-research” studies-should it be mandatory? J Clin Epidemiol. 2019;115:35–6.PubMed
95.
Lumley T, Keech A. Meta-meta-analysis with confidence. Lancet. 1995;346(8974):576–7.PubMed
96.
Sáiz-Vazquez O, Puente-Martínez A, Ubillos-Landa S, Pacheco-Bonrostro J, Santabárbara J. Cholesterol and Alzheimer’s disease risk: a Meta-Meta-analysis. Brain Sci. 2020;10(6):386.PubMedCentral
97.
Faggion CM Jr, Diaz KT. Overview authors rarely defined systematic reviews that are included in their overviews. J Clin Epidemiol. 2019;109:70–9.PubMed
98.
Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013;74(4):580–91.PubMed
99.
Bonaccio M, Di Castelnuovo A, Pounis G, Costanzo S, Persichillo M, Cerletti C, et al. High adherence to the Mediterranean diet is associated with cardiovascular protection in higher but not in lower socioeconomic groups: prospective findings from the Moli-sani study. Int J Epidemiol. 2017;46(5):1478–87.PubMed
100.
Liu QP, Wu YF, Cheng HY, Xia T, Ding H, Wang H, et al. Habitual coffee consumption and risk of cognitive decline/dementia: a systematic review and meta-analysis of prospective cohort studies. Nutrition. 2016;32(6):628–36.PubMed
101.
Vercambre MN, Berr C, Ritchie K, Kang JH. Caffeine and cognitive decline in elderly women at high vascular risk. J Alzheimers Dis. 2013;35(2):413–21.PubMed
102.
Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019;34(8):731–52.PubMed
103.
Stamp L, Dalbeth N. Urate-lowering therapy for asymptomatic hyperuricaemia: a need for caution. Semin Arthritis Rheumatism. 2017;46(4):457–64.PubMed
104.
Yang F, Trolle Lagerros Y, Bellocco R, Adami HO, Fang F, Pedersen NL, et al. Physical activity and risk of Parkinson’s disease in the Swedish National March Cohort. Brain. 2015;138(Pt 2):269–75.PubMed
105.
Iwaki H, Ando R, Miyaue N, Tada S, Tsujii T, Yabe H, et al. One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan. J Neurol Sci. 2017;383:75–8.PubMed
106.
Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, et al. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014;71(2):141–50.PubMed
107.
Tanner CM, Comella CL. When brawn benefits brain: physical activity and Parkinson's disease risk. Brain. 2015;138(Pt 2):238–9.PubMedPubMedCentral
108.
Dardiotis E, Arseniou S, Sokratous M, Tsouris Z, Siokas V, Mentis AA, et al. Vitamin B12, folate, and homocysteine levels and multiple sclerosis: a meta-analysis. Mult Scler Relat Disord. 2017;17:190–7.PubMed
109.
Mentis AA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and multiple sclerosis: from mechanisms and pathways to translational research opportunities. Mol Neurobiol. 2017;54(5):3911–23.PubMed
110.
Benedict RH, Weinstock-Guttmam B, Marr K, Valnarov V, Kennedy C, Carl E, et al. Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis. BMC Med. 2013;11:167.PubMedPubMedCentral
111.
Tsivgoulis G, Faissner S, Voumvourakis K, Katsanos AH, Triantafyllou N, Grigoriadis N, et al. “Liberation treatment” for chronic cerebrospinal venous insufficiency in multiple sclerosis: the truth will set you free. Brain Behav. 2015;5(1):3–12.PubMed
112.
Wang M-D, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology. 2017;61:101–30.PubMed
113.
Pingault J-B, O’reilly PF, Schoeler T, Ploubidis GB, Rijsdijk F, Dudbridge F. Using genetic data to strengthen causal inference in observational research. Nat Rev Genet. 2018;19(9):566.PubMed
114.
van der Mei I, Lucas RM, Taylor BV, Valery PC, Dwyer T, Kilpatrick TJ, et al. Population attributable fractions and joint effects of key risk factors for multiple sclerosis. Mult Scler. 2016;22(4):461–9.PubMed
115.
Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25–36.PubMed
116.
Ascherio A, Munger KL, Lunemann JD. The initiation and prevention of multiple sclerosis. Nat Rev Neurol. 2012;8(11):602–12.PubMedPubMedCentral
117.
Koukouli F, Rooy M, Tziotis D, Sailor KA, O'Neill HC, Levenga J, et al. Nicotine reverses hypofrontality in animal models of addiction and schizophrenia. Nat Med. 2017;23(3):347–54.PubMedPubMedCentral
118.
Papatheodorou SI, Tsilidis KK, Evangelou E, Ioannidis JP. Application of credibility ceilings probes the robustness of meta-analyses of biomarkers and cancer risk. J Clin Epidemiol. 2015;68(2):163–74.PubMed
119.
Machado MO, Veronese N, Sanches M, Stubbs B, Koyanagi A, Thompson T, et al. The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses. BMC Med. 2018;16(1):112.PubMedPubMedCentral
120.
Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011;26(Suppl 1):S1–58.PubMed
121.
Mentis A-FA. Social determinants of tobacco use: towards an equity lens approach Tob Prev Cessation. 2017;3(7).
122.
Grimshaw G, Stanton A. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2006;4.
123.
Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. The Lancet Neurology. 2010;9(7):727–39.PubMed
124.
Mentis A-FA, Pantelidi K, Dardiotis E, Hadjigeorgiou GM, Petinaki E. Precision medicine and global health: the good, the bad, and the ugly. Front Med. 2018;5:67.
125.
McKay KA, Tremlett H. The systematic search for risk factors in multiple sclerosis. Lancet Neurol. 2015;14(3):237–8.PubMed
126.
Paez-Colasante X, Figueroa-Romero C, Sakowski SA, Goutman SA, Feldman EL. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat Rev Neurol. 2015;11(5):266–79.PubMed
127.
Wang MD, Gomes J, Cashman NR, Little J, Krewski D. A meta-analysis of observational studies of the association between chronic occupational exposure to lead and amyotrophic lateral sclerosis. J Occup Environ Med. 2014;56(12):1235–42.PubMedPubMedCentral
128.
Peters TL, Beard JD, Umbach DM, Allen K, Keller J, Mariosa D, et al. Blood levels of trace metals and amyotrophic lateral sclerosis. Neurotoxicology. 2016;54:119–26.PubMedPubMedCentral
129.
Sauzéat L, Bernard E, Perret-Liaudet A, Quadrio I, Vighetto A, Krolak-Salmon P, et al. Isotopic evidence for disrupted copper metabolism in amyotrophic lateral sclerosis. iScience. 2018;6:264–71.PubMedPubMedCentral
130.
Visser AE, D'Ovidio F, Peters S, Vermeulen RC, Beghi E, Chiò A, et al. Multicentre, population-based, case–control study of particulates, combustion products and amyotrophic lateral sclerosis risk. J Neurol Neurosurg Psychiatry. 2019;90:854–60.
131.
Savica R, Rocca WA, Ahlskog JE. When does Parkinson disease start? Arch Neurol. 2010;67(7):798–801.PubMed
132.
Engelender S, Isacson O. The threshold theory for Parkinson’s disease. Trends Neurosci. 2017;40(1):4–14.PubMed
133.
Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119(6):689–702.PubMedPubMedCentral
134.
Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson’s disease. Neuron. 2019;103:627–641.e7.
135.
Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ, Vepa Y, et al. The vermiform appendix impacts the risk of developing Parkinson's disease. Science translational medicine. 2018;10(465):eaar5280.
136.
Hopfner F, Höglinger GU, Kuhlenbäumer G, Pottegård A, Wod M, Christensen K, et al. β-adrenoreceptors and the risk of Parkinson’s disease. Lancet Neurol. 2020;19(3):247–54.PubMed
137.
138.
Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF 3rd. Late-life depression and risk of vascular dementia and Alzheimer’s disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329–35.PubMedPubMedCentral
139.
Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health. 2014;14:643.PubMedPubMedCentral
140.
Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry. 2015;86(12):1299–306.PubMed
141.
Fratiglioni L, Wang H-X. Brain reserve hypothesis in dementia. J Alzheimers Dis. 2007;12(1):11–22.PubMed
142.
Frieden TR. SHATTUCK LECTURE: the future of public health. New England J Med. 2015;373(18):1748–54.
143.
Naik Y, Baker P, Ismail SA, Tillmann T, Bash K, Quantz D, et al. Going upstream–an umbrella review of the macroeconomic determinants of health and health inequalities. BMC Public Health. 2019;19(1):1678.PubMedPubMedCentral
144.
145.
Ham C. Improving the performance of health services: the role of clinical leadership. Lancet. 2003;361(9373):1978–80.PubMed
146.
Reich MR, Takemi K, Roberts MJ, Hsiao WC. Global action on health systems: a proposal for the Toyako G8 summit. Lancet. 2008;371(9615):865–9.
147.
Rasooly D, Ioannidis JPA, Khoury MJ, Patel CJ. Family history-wide association study (“FamWAS”) for identifying clinical and environmental risk factors for common chronic diseases. Am J Epidemiol. 2019;.
148.
Chrousos GP, Kino T. Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders. Ann N Y Acad Sci. 2009;1179:153–66.PubMedPubMedCentral
149.
Yu K, Lv J, Qiu G, Yu C, Guo Y, Bian Z, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study. Lancet Glob Health. 2020;8(3):e430–e9.PubMedPubMedCentral
150.
Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019;7(6):e748–e60.PubMed
151.
Lilford R, Kyobutungi C, Ndugwa R, Sartori J, Watson SI, Sliuzas R, et al. Because space matters: conceptual framework to help distinguish slum from non-slum urban areas. BMJ Glob Health. 2019;4(2):e001267.PubMedPubMedCentral
152.
Willett WC, Ludwig DS. Milk and health. N Engl J Med. 2020;382(7):644–54.PubMed
153.
Berman MG, Kardan O, Kotabe HP, Nusbaum HC, London SE. The promise of environmental neuroscience. Nat Hum Behav. 2019;3(5):414–7.PubMed
154.
O'Sullivan JW, Muntinga T, Grigg S, Ioannidis JPA. Prevalence and outcomes of incidental imaging findings: umbrella review. Bmj. 2018;361:k2387.PubMedPubMedCentral
155.
156.
Kamoen O, Maqueda V, Yperzeele L, Pottel H, Cras P, Vanhooren G, et al. Stroke coach: a pilot study of a personal digital coaching program for patients after ischemic stroke. Acta Neurol Belg. 2020;120(1):91–7.PubMed
157.
Leonenko G, Sims R, Shoai M, Frizzati A, Bossu P, Spalletta G, et al. Polygenic risk and hazard scores for Alzheimer’s disease prediction. Ann Clin Transl Neurol. 2019;6(3):456–65.PubMedPubMedCentral
158.
159.
Armon C, Traynor BJ. High BMI is associated with low ALS risk: what does it mean? Neurology. 2019;93(5):189–91.PubMed
160.
Husain M, Roiser JP. Neuroscience of apathy and anhedonia: a transdiagnostic approach. Nat Rev Neurosci. 2018;19(8):470–84.PubMed
161.
162.
Ritchie K, Carriere I, Ritchie CW, Berr C, Artero S, Ancelin ML. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ. 2010;341:c3885.PubMedPubMedCentral
163.
Silagy CA, Middleton P, Hopewell S. Publishing protocols of systematic reviews: comparing what was done to what was planned. JAMA. 2002;287(21):2831–4.PubMed
164.
Baron R, Ferriero DM, Frisoni GB, Bettegowda C, Gokaslan ZL, Kessler JA, et al. Neurology—the next 10 years. Nat Rev Neurol. 2015;11(11):658.PubMed
165.
Prasad V. Our best weapons against cancer are not magic bullets. Nature. 2020;577(7791):451.PubMed
166.
167.
Wang MD, Little J. How credible are meta-analyses of risk factors based on observational studies for amyotrophic lateral sclerosis a new insight from an umbrella review. Neuroepidemiology. 2016;46(4):271–2.PubMed
168.
Prüss-Ustün A, van Deventer E, Mudu P, Campbell-Lendrum D, Vickers C, Ivanov I, et al. Environmental risks and non-communicable diseases. Bmj. 2019;364:l265.PubMedPubMedCentral
169.
Organization WH, Canada PHAo, Canada CPHAo. Preventing chronic diseases: a vital investment. Geneva: World Health Organization; 2005.
170.
Perkins JM, Subramanian S, Christakis NA. Social networks and health: a systematic review of sociocentric network studies in low-and middle-income countries. Soc Sci Med. 2015;125:60–78.PubMed
171.
Lahiri DK, Maloney B, Bayon BL, Chopra N, White FA, Greig NH, et al. Transgenerational latent early-life associated regulation unites environment and genetics across generations. Epigenomics. 2016;8(3):373–87.PubMedPubMedCentral
172.
Mentis AFA. To what extent are Greek children exposed to the risk of a lifelong, intergenerationally transmitted poverty? Poverty Public Policy. 2015;7(4):357–81.
173.
Lahiri DK, Maloney B. The “LEARn”(latent early-life associated regulation) model integrates environmental risk factors and the developmental basis of Alzheimer’s disease, and proposes remedial steps. Exp Gerontol. 2010;45(4):291–6.PubMedPubMedCentral
174.
Wells JC. The capacity–load model of non-communicable disease risk: understanding the effects of child malnutrition, ethnicity and the social determinants of health. Eur J Clin Nutr. 2018;72(5):688–97.PubMed
175.
Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet. 1990;335(8695):939–40.PubMed
176.
Turner MC, Vineis P, Seleiro E, Dijmarescu M, Balshaw D, Bertollini R, et al. EXPOsOMICS: final policy workshop and stakeholder consultation. BMC Public Health. 2018;18(1):260.PubMedPubMedCentral
177.
Charmandari E, Achermann JC, Carel JC, Soder O, Chrousos GP. Stress response and child health. Science Signal. 2012;5(248):mr1.
178.
Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5(7):374.PubMed
179.
Chrousos GP, Kino T. Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress. 2007;10(2):213–9.PubMed
180.
Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab. 1994;79(3):848–53.PubMed
181.
Gassen NC, Chrousos GP, Binder EB, Zannas AS. Life stress, glucocorticoid signaling, and the aging epigenome: implications for aging-related diseases. Neurosci Biobehav Rev. 2017;74(Pt B):356–65.PubMed
182.
Moher D, Klassen TP, Schulz KF, Berlin JA, Jadad AR, Liberati A. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol. 2000;53(9):964–72.PubMed
183.
Vink A, Hanser S. Music-based therapeutic interventions for people with dementia: a mini-review. Medicines. 2018;5(4):109.PubMedCentral
184.
He Y, Li X, Gasevic D, Brunt E, McLachlan F, Millenson M, et al. Statins and multiple noncardiovascular outcomes: umbrella review of meta-analyses of observational studies and randomized controlled trials. Ann Intern Med. 2018;169(8):543–53.PubMed
185.
Xy H, Lin J, Ww G. Risk factors and therapies in vascular diseases: an umbrella review of updated systematic reviews and meta-analyses. J Cell Physiol. 2019;234(6):8221–32.
186.
Li N, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, et al. Soy and isoflavone consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomized trials in humans. Mol Nutr Food Res. 2020;64(4):1900751.
187.
Dragioti E, Solmi M, Favaro A, Fusar-Poli P, Dazzan P, Thompson T, et al. Association of antidepressant use with adverse health outcomes: a systematic umbrella review. JAMA Psychiatry. 2019;76(12):1241–55.PubMedPubMedCentral
188.
Seitz MW, Listl S, Bartols A, Schubert I, Blaschke K, Haux C, et al. Current knowledge on correlations between highly prevalent dental conditions and chronic diseases: an umbrella review [dataset]. 2019.
189.
Ehsan A, Klaas HS, Bastianen A, Spini D. Social capital and health: a systematic review of systematic reviews. SSM-Popul Health. 2019;8:100425.PubMedPubMedCentral
190.
Wan Q, Li N, Du L, Zhao R, Yi M, Xu Q, et al. Allium vegetable consumption and health: an umbrella review of meta-analyses of multiple health outcomes. Food Sci Nutr. 2019;7(8):2451–70.PubMedPubMedCentral
191.
Grabovac I, Veronese N, Stefanac S, Haider S, Jackson SE, Koyanagi A, et al. Human immunodeficiency virus infection and diverse physical health outcomes: an umbrella review of meta-analyses of observational studies. Cli Infect Dis. 2020;70(9):1809–15.
192.
Marventano S, Godos J, Tieri M, Ghelfi F, Titta L, Lafranconi A, et al. Egg consumption and human health: an umbrella review of observational studies. Int J Food Sci Nutr. 2020;71(3):325–31.PubMed
193.
Khan SU, Khan MU, Riaz H, Valavoor S, Zhao D, Vaughan L, et al. Effects of nutritional supplements and dietary interventions on cardiovascular outcomes: an umbrella review and evidence map. Ann Intern Med. 2019;171(3):190–8.PubMedPubMedCentral
194.
Yi M, Wu X, Zhuang W, Xia L, Chen Y, Zhao R, et al. Tea consumption and health outcomes: umbrella review of meta-analyses of observational studies in humans. Mol Nutr Food Res. 2019;63(16):1900389.
195.
Godos J, Tieri M, Ghelfi F, Titta L, Marventano S, Lafranconi A, et al. Dairy foods and health: an umbrella review of observational studies. Int J Food Sci Nutr. 2020;71(2):138–51.PubMed
196.
Smith L, Luchini C, Demurtas J, Soysal P, Stubbs B, Hamer M, et al. Telomere length and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational studies. Ageing Res Rev. 2019;51:1–10.PubMed
197.
Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, et al. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2020;59(1):263–72.PubMed
198.
Angelino D, Godos J, Ghelfi F, Tieri M, Titta L, Lafranconi A, et al. Fruit and vegetable consumption and health outcomes: an umbrella review of observational studies. Int J Food Sci Nutr. 2019;70(6):652–67.PubMed
199.
Wallace TC, Bailey RL, Blumberg JB, Burton-Freeman B, Chen CO, Crowe-White KM, et al. Fruits, vegetables, and health: a comprehensive narrative, umbrella review of the science and recommendations for enhanced public policy to improve intake. Crit Rev Food Sci Nutr. 2020;60(13):2174–211.PubMed
200.
Kelly MM, Griffith PB. The influence of preterm birth beyond infancy: umbrella review of outcomes of adolescents and adults born preterm. J Am Assoc Nurse Pract. 2020;32(8):555–62.PubMed
201.
Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Rahelić D, Kahleová H, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11(2):338.PubMedCentral
202.
Viguiliouk E, Glenn AJ, Nishi SK, Chiavaroli L, Seider M, Khan T, et al. Associations between dietary pulses alone or with other legumes and cardiometabolic disease outcomes: an umbrella review and updated systematic review and meta-analysis of prospective cohort studies. Adv Nutr. 2019;10(Supplement_4):S308–S19.PubMedPubMedCentral
203.
Fewell Z, Davey Smith G, Sterne JA. The impact of residual and unmeasured confounding in epidemiologic studies: a simulation study. Am J Epidemiol. 2007;166(6):646–55.PubMed
204.
Kleinberg S, Hripcsak G. A review of causal inference for biomedical informatics. J Biomed Informatics. 2011;44(6):1102–12.
205.
Patel CJ, Burford B, Ioannidis JPA. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. J Clin Epidemiol. 2015;68(9):1046–58.PubMedPubMedCentral
206.
Schooling CM, Jones HE. Clarifying questions about “risk factors”: predictors versus explanation. Emerg Themes Epidemiol. 2018;15(1):10.PubMedPubMedCentral
207.
Mentis AFA, Papavassiliou AG. Correcting “insertion-deletion mutations” in medical terminology. J Cell Mol Med. 2018;22(12):6408.PubMedPubMedCentral
208.
Smith GD, Ebrahim S. Epidemiology—is it time to call it a day? Oxford: Oxford University Press; 2001.
209.
Lodi S, Phillips A, Lundgren J, Logan R, Sharma S, Cole SR, et al. Effect estimates in randomized trials and observational studies: comparing apples with apples. Am J Epidemiol. 2019;188(8):1569–77.PubMedPubMedCentral
210.
Pinnock H, Parke HL, Panagioti M, Daines L, Pearce G, Epiphaniou E, et al. Systematic meta-review of supported self-management for asthma: a healthcare perspective. BMC Med. 2017;15(1):64.PubMedPubMedCentral
211.
Heslehurst N, Brown H, Pemu A, Coleman H, Rankin J. Perinatal health outcomes and care among asylum seekers and refugees: a systematic review of systematic reviews. BMC Med. 2018;16(1):89.PubMedPubMedCentral
212.
Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014;13(2):153–60.PubMedPubMedCentral
213.
Garcia-Rudolph A, Sanchez-Pinsach D, Salleras EO, Tormos JM. Subacute stroke physical rehabilitation evidence in activities of daily living outcomes: a systematic review of meta-analyses of randomized controlled trials. Medicine. 2019;98(8):e14501.PubMedPubMedCentral
214.
Donnan J, Walsh S, Fortin Y, Gaskin J, Sikora L, Morrissey A, et al. Factors associated with the onset and progression of neurotrauma: a systematic review of systematic reviews and meta-analyses. Neurotoxicology. 2017;61:234–41.PubMed
215.
Chalkias A, Ioannidis JPA. Interventions to improve cardiopulmonary resuscitation: a review of meta-analyses and future agenda. Critical care (London). 2019;23(1):210.
216.
Paquette M, Alotaibi AM, Nieuwlaat R, Santesso N, Mbuagbaw L. A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation. Syst Rev. 2019;8(1):241.PubMedPubMedCentral
217.
Hazar N, Seddigh L, Rampisheh Z, Nojomi M. Population attributable fraction of modifiable risk factors for Alzheimer disease: a systematic review of systematic reviews. Iran J Neurol. 2016;15(3):164–72.PubMedPubMedCentral
218.
Martinic MK, Pieper D, Glatt A, Puljak L. Definition of a systematic review used in overviews of systematic reviews, meta-epidemiological studies and textbooks. BMC Med Res Methodol. 2019;19(1):203.
219.
Zhou X, Menche J, Barabási A-L, Sharma A. Human symptoms–disease network. Nat Commun. 2014;5:4212.PubMed
220.
Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, et al. Uncovering disease-disease relationships through the incomplete interactome. Science. 2015;347(6224):1257601.PubMedPubMedCentral
221.
Adam D. The gene-based hack that is revolutionizing epidemiology. Nature. 2019;576(7786):196–9.PubMed
222.
Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, et al. Living systematic review: 1. Introduction—the why, what, when, and how. J Clin Epidemiol. 2017;91:23–30.PubMed
223.
Belbasis L, Bellou V, Evangelou E, Tzoulaki I. Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies. Mult Scler. 2020;26(4):397–404.PubMed
224.
Macdonald H, Loder E, Abbasi K. Living systematic reviews at the BMJ. BMJ. 2020;370:m2925.PubMed
Metadata
Title
Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews
Authors
Alexios-Fotios A. Mentis
Efthimios Dardiotis
Vasiliki Efthymiou
George P. Chrousos
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-020-01873-7

Other articles of this Issue 1/2021

BMC Medicine 1/2021 Go to the issue

Research article

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

Research article

Genome-wide association study followed by trans-ancestry meta-analysis identify 17 new risk loci for schizophrenia

Research article

The risk of ischemic stroke and hemorrhagic stroke in Chinese adults with low-density lipoprotein cholesterol concentrations < 70 mg/dL

Research article

Associations of six adiposity-related markers with incidence and mortality from 24 cancers—findings from the UK Biobank prospective cohort study

Database

SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries

Research article

Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer’s disease